US Patent 10626129 Heteroaryl inhibitors of PDE4
Patent 10626129 was granted and assigned to Tetra Therapeutics on April, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 26, 2019
Date of Patent
April 21, 2020
Patent Applicant
Patent Application Number
16396457
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10626129 Heteroaryl inhibitors of PDE4
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.